Scroll down

With over 15 years of experience working with live viruses, our track record includes viruses such as:

• Herpesvirus (HSV)
• Vesicular stomatitis virus (VSV)
• Adenovirus
• Adeno Associated Virus (AAV)
• Pox-like-viruses, such as Fowlpox and Modified vaccinia virus ankara (MVA)
• Influenza
• Newcastle-Disease Virus (NDV)
• Respiratory Syncytial Virus (RSV)
• Infectious Bursal Disease Virus (IBDV)
• Cytomegalovirus (CMV)

We also have an established history producing viruses in various culture vessels, including shake flasks, single-use suspension bioreactors, disposable iCELLis® fixed-bed bioreactors, T-flasks, roller bottles and CellSTACK®s, making us the ideal CDMO for your virotherapy product.

From our facility in Germany, we have the expertise to develop and produce both cell-based (suspension and adherent) and egg-based viruses. We provide complete upstream and downstream processing, analytical testing (including method transfer, development, and validation) and fill/finish services that are specifically designed for the production of virotherapies.


Our virotherapy capabilities span the development of oncolytic viruses, viral vector gene therapies and viral vector vaccines (prophylactic or therapeutic). Find out more:


At Vibalogics we offer a variety of platforms depending on the requirements for your project. We have decades of experience in the development and production of both cell-based (suspension and adherent) and egg-based viruses. Find out more:


Working in compliance with international GMP standards in a BSL-2 classified state-of-the-art facility in Germany, we offer a full range of development and manufacturing services.